Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by palinc2000on Mar 22, 2024 11:04am
70 Views
Post# 35947140

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New Press Release - Theratechnologies Appoints Jordan Zwick to its Board of Directors

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New Press Release - Theratechnologies Appoints Jordan Zwick to its Board of Directorsoups

AS I DONT have any confidence........

palinc2000 wrote: I would love confirmation that he is in fact the  Soleus nominee.....as I have any confidence in the BOD and management....Why did they wait so long to recognize that they were running towards a brickwall ....There is a  Quebec slang expression which is hard to translate but it is really what best describes mgmt and the the BOD    LES DEUX PIEDS DANS LA MEME BOTTINE      
It certainly fits Paul who was unable to take decisive actions which could have prevented hitting the brickwall....Hope for the best but prepare for the worst is my favorite motto.....Paul and the whole crew did exactly the opposite

The Compagny is not dead .....today is the first day that I can say that it is on the mend .....long recovery but help is on the way

PWIB123 wrote: I'm certainly pessimistic about everything at this point.  The new board member has an incredible range of skillsets, but not just on paper, there's published articles regarding a number of his accomplishments.  He brings a financial and analytical background combined with operational experience that PL just doesn't have.  

Kd5513 wrote: I would be cautious in regards to LinkedIn being a great source for actual accomplishment. It is a tool many use to buff their resumes and experience with recommendations. To his credentials that sounds great, but again PL was supposed to be very established as well.

I hope I am wrong and this guy is the cats meow. with recent cost cutting announcement it wouldnt surprise if all cancer is dead pretty quickly and we have just hemorrgged $ from poor leadership and a pipe dream of miracle drug in cancer.

Again I hope that I am wrong.






<< Previous
Bullboard Posts
Next >>